Evidence map›Paper›PMID 37666699›Full record

ArticleZeitschrift fur medizinische Physik2024

Development and clinical implementation of a digital system for risk assessments for radiation therapy.

Dominik Kornek, David Menichelli, Jörg Leske, Michael Hofmann, David Antkiewicz, Tobias Brandt, Oliver J Ott, Michael Lotter, Marga Lang-Welzenbach, Rainer Fietkau and 1 more

Abstract read
In one paragraph

Article in Zeitschrift fur medizinische Physik, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Radiation incident learning in multi-site centers.Journal of applied clinical medical physics · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Risk management in radiation-based therapies.Zeitschrift fur medizinische Physik · 2024
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dominik KornekDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany. Electronic address: dominik.kornek@uk-erlangen.de.
David MenichelliIBA Dosimetry GmbH, 90592 Schwarzenbruck, Germany. Electronic address: David.Menichelli@iba-group.com.
Jörg LeskeIBA Dosimetry GmbH, 90592 Schwarzenbruck, Germany. Electronic address: Joerg.Leske@iba-group.com.
Michael HofmannIBA Dosimetry GmbH, 90592 Schwarzenbruck, Germany. Electronic address: Michael.Hofmann@iba-group.com.
David AntkiewiczIBA Dosimetry GmbH, 90592 Schwarzenbruck, Germany. Electronic address: David.Antkiewicz@iba-group.com.
Tobias BrandtDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany. Electronic address: Tobias.Brandt@uk-erlangen.de.
Oliver J OttDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany. Electronic address: Oliver.Ott@uk-erlangen.de.
Michael LotterDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany. Electronic address: Michael.Lotter@uk-erlangen.de.
Marga Lang-WelzenbachDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany. Electronic address: Marga.Lang-Welzenbach@uk-erlangen.de.
Rainer FietkauDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany. Electronic address: Rainer.Fietkau@uk-erlangen.de.
Christoph BertDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany. Electronic address: Christoph.Bert@uk-erlangen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Before introducing new treatment techniques, an investigation of hazards due to unintentional radiation exposures is a reasonable activity for proactively increasing patient safety. As dedicated software is scarce, we developed a tool for risk assessment to design a quality management program based on best practice methods, i.e., process mapping, failure modes and effects analysis and fault tree analysis. Implemented as a web database application, a single dataset was used to describe the treatment process and its failure modes. The design of the system and dataset allowed failure modes to be represented both visually as fault trees and in a tabular form. Following the commissioning of the software for our department, previously conducted risk assessments were migrated to the new system after being fully re-assessed which revealed a shift in risk priorities. Furthermore, a weighting factor was investigated to bring risk levels of the migrated assessments into perspective. The compensation did not affect high priorities but did re-prioritize in the midrange of the ranking. We conclude that the tool is suitable to conduct multiple risk assessments and concomitantly keep track of the overall quality management activities.

Indexed as

RadiotherapyHumansRisk AssessmentSoftwareFailure modes and effects analysis (FMEA)Fault tree analysis (FTA)Process throughputRadiation therapyRisk analysisRisk-based quality management

Identifiers

PMID37666699
PMCPMC11384085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.